U.S. Will Pay $1.6 Billion to Novavax for Coronavirus Vaccine

The Maryland-based company, which has never brought a product to market before, just made the biggest deal to date with the Trump administration’s Operation Warp Speed.
By BY KATIE THOMAS from NYT Health https://ift.tt/2AEWUhm
via IFTTT
your-feed-science, Clinical Trials, Vaccination and Immunization, Coronavirus (2019-nCoV)
Source New York Times
Làm đẹp Blog 247